IP Library Granted Patent US 8,679,552
Granted Patent B2
US 8,679,552 · App. 13/658,674 · Granted Mar 25, 2014

Acne vulgaris treatment regimen

Inventor: B. Eugene Guthery (Texarkana, TX)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,552
App. No.
13/658,674
Granted
Mar 25, 2014
Kind
B2
Abstract

A kit for treatment of acne vulgaris, said formulation of the kit effectively inhibiting or killing Proprionibacterium without antibiotics. A preferred formulation alleviates the four pathogenic factors of acne. In a preferred method using the kit, a first skin-wash formulation comprising a higher zinc pyrithione concentration than the second leave-on formulation is applied to the affected area and subsequently washed off the skin with water. Then, a second leave-on formulation, preferably comprising a minimum of 0.25% zinc pyrithione with additional ingredients for eliminating or reducing other pathogenic factors of acne vulgaris, is applied to the skin. The kit includes a skin-wash component and a leave-on component comprising the acne treatment of the invention. Formulations are preferably applied as creams, lotions or emulsions.

Claims (28)

1. A kit for treatment of acne, consisting essentially of:

a. a first container of about 1.0% to about 2.5% zinc pyrithione; and

b. a second container of at least 0.25% zinc pyrithione, therapeutically effective amounts of linoleic acid, and a gallic acid ester selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof.

2. The kit according to claim 1 , wherein the contents of said first container are in cream form.

3. The kit according to claim 1 , wherein the contents of said second container are in cream form.

4. The kit according to claim 1 , wherein the contents of said first container are in lotion form.

5. The kit according to claim 1 , wherein the contents of said second container are in lotion form.

6. The kit according to claim 1 , wherein the contents of said first container are in emulsion form.

7. The kit according to claim 1 , wherein the contents of said second container are in emulsion form.

8. A kit for treatment of acne, consisting essentially of:

a. a first container having salicylic acid and about 1.0% to about 2.5% zinc pyrithione; and

b. a second container of at least 0.25% zinc pyrithione, therapeutically effective amounts of linoleic acid, and a gallic acid ester selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof.

9. The kit according to claim 8 , wherein the contents of said first container are in cream form.

10. The kit according to claim 8 , wherein the contents of said second container are in cream form.

11. The kit according to claim 8 , wherein the contents of said first container are in lotion form.

12. The kit according to claim 8 , wherein the contents of said second container are in lotion form.

13. The kit according to claim 8 , wherein the contents of said first container are in emulsion form.

14. The kit according to claim 8 , wherein the contents of said second container are in emulsion form.

15. A kit for treatment of acne, consisting essentially of:

a. a first container of about 1.0% to about 2.5% zinc pyrithione; and

b. a second container of at least 0.25% zinc pyrithione, therapeutically effective amounts of linoleic acid, and a gallic acid ester selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof, and

therapeutically effective amounts of an additional active ingredient selected from the group consisting of: salicylic acid, retinaldehyde, gamma-linolenic acid, cis 4,7,10,13,16,19-docosahexaenoic acid, cis-6,9,12,15-octatetraenoic acid, arachidonic acid, alpha-linolenic acid, palmitoleic acid, oleic acid, myristoleic acid, zinc salt, pyridoxine hydrochloride, azelaic acid, green tea catechins, flavonoids, isoflavonoids, ethyl laurate, ethyl linoleate, beta-sitosterol, progesterone, spironolactone, Vitamin E, nordihydroguaiaretic acid, dexpanthenol, glycyrrhetinic acid, and combinations thereof.

16. The kit according to claim 15 , wherein the contents of said first container are in cream form.

17. The kit according to claim 15 , wherein the contents of said second container are in cream form.

18. The kit according to claim 15 , wherein the contents of said first container are in lotion form.

19. The kit according to claim 15 , wherein the contents of said second container are in lotion form.

20. The kit according to claim 15 , wherein the contents of said first container are in emulsion form.

21. The kit according to claim 15 , wherein the contents of said second container are in emulsion form.

Continuity (3)
Continuation 13140559
Provisional Application 61138579 · Dec 18, 2008
Related Publication 20130289005A1 · Oct 31, 2013